WellCare Health Plans
What analysts say:
- Buy, sell, or hold?: Analysts think investors should stand pat on WellCare Health Plans with 10 of 12 analysts rating it hold. Analysts don't like WellCare Health Plans as much as competitor Centene overall. Eight out of 15 analysts rate Centene a buy compared to two of 12 for WellCare Health Plans. Analysts still rate the stock a hold, but they are a bit more wary about it compared to three months ago.
- Revenue forecasts: On average, analysts predict $1.59 billion in revenue this quarter. That would represent a rise of 16.9% from the year-ago quarter.
- Wall Street earnings expectations: The average analyst estimate is earnings of $1.15 per share. Estimates range from $1.02 to $1.32.
What our community says:
CAPS All-Stars are solidly backing the stock, with 95.7% awarding it an "outperform" rating. Most of the community concurs with the All-Stars, with 91.4% assigning it a rating of "outperform." Fools are bullish on WellCare Health Plans and haven't been shy with their opinions lately, logging 203 posts in the past 30 days. Despite the majority sentiment in favor of WellCare Health Plans, the stock has a middling CAPS rating of three out of five stars.
Revenue has now gone up for three straight quarters.
One final thing: If you want to keep tabs on WellCare Health Plans movements, and for more analysis on the company, make sure you add it to your Watchlist.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.Earnings estimates provided by Zacks.